Abstract
Achalasia is an esophageal motility disorder characterized by a non-relaxing lower esophageal sphincter and absent or significantly altered peristalsis. The underlying cause of most cases is unknown, with a small minority secondary to infectious, genetic, or obstructive etiologies. There is no cure. Palliative treatments include medical therapies and disruption of the lower esophageal sphincter. Botulinum toxin injection provides effective short-term relief but often lacks durability, thus lending itself to highly comorbid patients or in select diagnostic scenarios. Serial pneumatic dilations offer excellent symptom relief and durability, with rates comparable to surgical myotomy in appropriately selected patients. Peroral esophageal myotomy (POEM) is an established endoscopic therapy that offers robust dysphagia relief with minimized surgical morbidity. Patients who require reoperative achalasia surgery are at high risk for vagal nerve injury and gastroparesis. Emerging endoscopic therapies, such peroral pyloromyotomy (POP), may be an effective tool in this challenging patient population.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- EGD:
-
Esophagogastroduodenoscopy
- EGJ:
-
Esophagogastric junction
- G-POEM:
-
Gastric peroral endoscopic myotomy
- GERD:
-
Gastroesophageal reflux disease
- HRM:
-
High-resolution manometry
- LES:
-
Lower esophageal sphincter
- PD:
-
Pneumatic dilation
- POEM:
-
Peroral esophageal myotomy
- POP:
-
Peroral pyloromyotomy
References
Pandolfino JE, Gawron AJ. Achalasia: a systematic review. JAMA. 2015;313(18):1841–52.
Kahrilas PJ, Bredenoord AJ, Fox M, Gyawali CP, Roman S, Smout AJPM, et al. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27(2):160–74.
Hoogerwerf WA, Pasricha PJ. Pharmacologic therapy in treating achalasia. Gastrointest Endosc Clin N Am. 2001;11(2):311–24, vii.
Annese V, Bassotti G, Coccia G, Dinelli M, D’Onofrio V, Gatto G, et al. A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. Gut. 2000;46(5):597–600.
Lake JM, Wong RKH. Review article: the management of achalasia – a comparison of different treatment modalities. Aliment Pharmacol Ther. 2006;24(6):909–18.
Vaezi MF, Felix VN, Penagini R, Mauro A, de Moura EGH, Pu LZCT, et al. Achalasia: from diagnosis to management. Ann N Y Acad Sci. 2016;1381(1):34–44.
Moonen A, Annese V, Belmans A, Bredenoord AJ, Bruley des Varannes S, Costantini M, et al. Long-term results of the European achalasia trial: a multicentre randomised controlled trial comparing pneumatic dilation versus laparoscopic Heller myotomy. Gut. 2016;65(5):732–9.
Persson J, Johnsson E, Kostic S, Lundell L, Smedh U. Treatment of achalasia with laparoscopic myotomy or pneumatic dilatation: long-term results of a prospective, randomized study. World J Surg. 2015;39(3):713–20.
Novais PA, Lemme EM. 24-h pH monitoring patterns and clinical response after achalasia treatment with pneumatic dilation or laparoscopic Heller myotomy. Aliment Pharmacol Ther. 2010;32(10):1257–65.
Kostic S, Kjellin A, Ruth M, Lönroth H, Johnsson E, Andersson M, et al. Pneumatic dilatation or laparoscopic cardiomyotomy in the management of newly diagnosed idiopathic achalasia. Results of a randomized controlled trial. World J Surg. 2007;31(3):470–8.
Boeckxstaens GE, Annese V, des Varannes SB, Chaussade S, Costantini M, Cuttitta A, et al. Pneumatic dilation versus laparoscopic Heller’s myotomy for idiopathic achalasia. N Engl J Med. 2011;364(19):1807–16.
Rohof WO, Lei A, Boeckxstaens GE. Esophageal stasis on a timed barium esophagogram predicts recurrent symptoms in patients with long-standing achalasia. Am J Gastroenterol. 2012;108:49.
Rohof WO, Salvador R, Annese V, Bruley des Varannes S, Chaussade S, Costantini M, et al. Outcomes of treatment for achalasia depend on manometric subtype. Gastroenterology. 2013;144(4):718–25.
Inoue H, Minami H, Kobayashi Y, Sato Y, Kaga M, Suzuki M, et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy. 2010;42(4):265–71.
Stavropoulos SN, Modayil RJ, Friedel D, Savides T. The International Per Oral Endoscopic Myotomy Survey (IPOEMS): a snapshot of the global POEM experience. Surg Endosc. 2013;27(9):3322–38.
Teitelbaum EN, Dunst CM, Reavis KM, Sharata AM, Ward MA, DeMeester SR, et al. Clinical outcomes 5 years after POEM for treatment of primary esophageal motility disorders. Surg Endosc. 2018;32(1):421–7.
Werner YB, Costamagna G, Swanström LL, von Renteln D, Familiari P, Sharata AM, et al. Clinical response to peroral endoscopic myotomy in patients with idiopathic achalasia at a minimum follow-up of 2 years. Gut. 2016;65(6):899–906.
Chen X, Li Q-P, Ji G-Z, Ge X-X, Xhang X-H, Zhao X-Y, et al. A 2-year follow-up for 45 patients with achalasia who underwent peroral endoscopic myotomy. Eur J Cardiothorac Surg. 2015;47(5):890–6.
Inoue H, Sato H, Ikeda H, Onimaru M, Sato C, Minami H, et al. Per-oral endoscopic myotomy: a series of 500 patients. J Am Coll Surg. 2015;221(2):256–64.
Hungness ES, Sternbach JM, Teitelbaum EN, Kahrilas PJ, Pandolfino JE, Soper NJ. Per-oral endoscopic myotomy (POEM) after the learning curve: durable long-term results with a low complication rate. Ann Surg. 2016;264(3):508–17.
Li Q-L, Wu Q-N, Zhang X-C, Xu M-D, Zhang W, Chen S-Y, et al. Outcomes of per-oral endoscopic myotomy for treatment of esophageal achalasia with a median follow-up of 49 months. Gastrointest Endosc. 2018;87(6):1405–12.e3.
Crespin OM, Liu LWC, Parmar A, Jackson TD, Hamid J, Shlomovitz E, et al. Safety and efficacy of POEM for treatment of achalasia: a systematic review of the literature. Surg Endosc. 2017;31(5):2187–201.
Navas CM, Patel NK, Lacy BE. Gastroparesis: medical and therapeutic advances. Dig Dis Sci. 2017;62(9):2231–40.
Abell TL, Van Cutsem E, Abrahamsson H, Huizinga JD, Konturek JW, Galmiche JP, et al. Gastric electrical stimulation in intractable symptomatic gastroparesis. Digestion. 2002;66(4):204–12.
Shada AL, Dunst CM, Pescarus R, Speer EA, Cassera M, Reavis KM, et al. Laparoscopic pyloroplasty is a safe and effective first-line surgical therapy for refractory gastroparesis. Surg Endosc. 2016;30(4):1326–32.
Khashab MA, Stein E, Clarke JO, Saxena P, Kumbhari V, Chander Roland B, et al. Gastric peroral endoscopic myotomy for refractory gastroparesis: first human endoscopic pyloromyotomy (with video). Gastrointest Endosc. 2013;78(5):764–8.
Khashab MA, Ngamruengphong S, Carr-Locke D, Bapaye A, Benias PC, Serouya S, et al. Gastric per-oral endoscopic myotomy for refractory gastroparesis: results from the first multicenter study on endoscopic pyloromyotomy (with video). Gastrointest Endosc. 2017;85(1):123–8.
Bapaye A, Mahadik M, Pujari R, Vyas V, Dubale N. Per-oral endoscopic pyloromyotomy and per-oral endoscopic myotomy for coexisting refractory gastroparesis and recurrent achalasia cardia in a single patient. Gastrointest Endosc. 2016;84(4):734–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Society of American Gastrointestinal and Endoscopic Surgeons (SAGES)
About this chapter
Cite this chapter
Campagna, R.A.J., Hungness, E.S. (2020). Achalasia Management: Botox, Dilation, Peroral Esophageal Myotomy (POEM), Peroral Pyloromyotomy (POP). In: Nau, P., Pauli, E., Sandler, B., Trus, T. (eds) The SAGES Manual of Flexible Endoscopy. Springer, Cham. https://doi.org/10.1007/978-3-030-23590-1_13
Download citation
DOI: https://doi.org/10.1007/978-3-030-23590-1_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-23589-5
Online ISBN: 978-3-030-23590-1
eBook Packages: MedicineMedicine (R0)